Cargando…

New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses

BACKGROUND: PRR (Pattern Recognition Receptor) agonists have been widely tested as potent vaccine adjuvants. TLR7 (Toll-Like Receptor 7) and NOD2 (nucleotide-binding oligomerization domain 2) are key innate receptors widely expressed at mucosal levels. METHODS: Here, we evaluated the immunostimulato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gutjahr, Alice, Papagno, Laura, Vernejoul, Fabienne, Lioux, Thierry, Jospin, Fabienne, Chanut, Blandine, Perouzel, Eric, Rochereau, Nicolas, Appay, Victor, Verrier, Bernard, Paul, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393532/ https://www.ncbi.nlm.nih.gov/pubmed/32739871 http://dx.doi.org/10.1016/j.ebiom.2020.102922

Ejemplares similares

Induction of HIV mucosal immunity at distal sites after encapsulation of NOD1 and NOD2 ligands in biodegradable nanocarriers
por: Pavot, V, et al.
Publicado: (2012)

NOD2 deficiency increases retrograde transport of secretory IgA complexes in Crohn’s disease
por: Rochereau, Nicolas, et al.
Publicado: (2021)

Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
por: Guzelj, Samo, et al.
Publicado: (2022)

Exploiting Natural Cross-reactivity between Human Immunodeficiency Virus (HIV)-1 p17 Protein and Anti-gp41 2F5 Antibody to Induce HIV-1 Neutralizing Responses In Vivo
por: Verrier, Bernard, et al.
Publicado: (2017)

Impact of Dextran-Sodium-Sulfate-Induced Enteritis on Murine Cytomegalovirus Reactivation
por: Jentzer, Alexandre, et al.
Publicado: (2022)

Novel chimeric TLR2/NOD2 agonist CL429 exhibited significant radioprotective effects in mice
por: Cheng, Ying, et al.
Publicado: (2021)

Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent
por: Noailly, Blandine, et al.
Publicado: (2022)

Alteration of microbiota antibody‐mediated immune selection contributes to dysbiosis in inflammatory bowel diseases
por: Michaud, Eva, et al.
Publicado: (2022)

Mucosal Vaccination with Live Attenuated Bordetella bronchiseptica Protects against Challenge in Wistar Rats
por: Chamorro, Beatriz Miguelena, et al.
Publicado: (2023)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
por: Sun, Jinghua, et al.
Publicado: (2012)

STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice
por: Skouboe, Morten K., et al.
Publicado: (2018)

The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8(+) T-cell responses in vitro
por: Papagno, Laura, et al.
Publicado: (2020)

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
por: Arias, Mauricio A., et al.
Publicado: (2012)

Innate Immune Receptors in Human Airway Smooth Muscle Cells: Activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 Agonists
por: Månsson Kvarnhammar, Anne, et al.
Publicado: (2013)

Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice
por: Buffa, Viviana, et al.
Publicado: (2012)

Dectin-1 Is Essential for Reverse Transcytosis of Glycosylated SIgA-Antigen Complexes by Intestinal M Cells
por: Rochereau, Nicolas, et al.
Publicado: (2013)

Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer
por: Shukla, Nikunj M., et al.
Publicado: (2012)

Dietary fat differentially modulates the response of bone marrow-derived macrophages to TLR4 and NOD2 agonists
por: Shehat, Michael G., et al.
Publicado: (2023)

NOD1 Cooperates with TLR2 to Enhance T Cell Receptor-Mediated Activation in CD8 T Cells
por: Mercier, Blandine C., et al.
Publicado: (2012)

Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants
por: Strobl, Sebastian, et al.
Publicado: (2022)

The Nod2 Agonist Muramyl Dipeptide Cooperates with the TLR4 Agonist Lipopolysaccharide to Enhance IgG2b Production in Mouse B Cells
por: Lee, Sang-Hoon, et al.
Publicado: (2019)

Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703
por: Schmidt, Manuel, et al.
Publicado: (2015)

An efficient and scalable synthesis of potent TLR2 agonistic PAM(2)CSK(4)
por: Kaur, Arshpreet, et al.
Publicado: (2018)

A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
por: Van Hoeven, Neal, et al.
Publicado: (2017)

Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs
por: Wheat, William, et al.
Publicado: (2019)

The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine
por: Liang, Hong, et al.
Publicado: (2019)

Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin
por: Kim, Donghyun, et al.
Publicado: (2016)

Current knowledge and future directions of TLR and NOD signaling in sepsis
por: Foley, Niamh M, et al.
Publicado: (2015)

Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2021)

Induction of Potent Antigen-specific Cytotoxic T Cell Response by PLGA-nanoparticles Containing Antigen and TLR Agonist
por: Lee, Young-Ran, et al.
Publicado: (2013)

The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes
por: Dowling, David J., et al.
Publicado: (2013)

Modulation of TLR2, TLR4, TLR5, NOD1 and NOD2 receptor gene expressions and their downstream signaling molecules following thermal stress in the Indian major carp catla (Catla catla)
por: Basu, Madhubanti, et al.
Publicado: (2015)

Translocation of bacterial NOD2 agonist and its link with inflammation
por: Kim, Oh Yoen, et al.
Publicado: (2009)

Synthesis and validation of click-modified NOD1/2 agonists
por: Bharadwaj, Ravi, et al.
Publicado: (2023)

Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2022)

Genotype Delimitation in the Nod-Independent Model Legume Aeschynomene evenia
por: Arrighi, Jean-François, et al.
Publicado: (2013)

The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon
por: Krarup, Astrid Raaby, et al.
Publicado: (2017)

Targeting TLR9 agonists to secondary lymphoid organs induces potent immune responses against HBV infection
por: Ushach, Irina, et al.
Publicado: (2022)

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
por: Luchner, Marina, et al.
Publicado: (2021)

NOD1-Mediated Mucosal Host Defense against Helicobacter pylori
por: Watanabe, Tomohiro, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9a9tqdr1so0doqmocjj84a3ek5